Lataa...
Synergistic Neutralization of Pertussis Toxin by a Bispecific Antibody In Vitro and In Vivo
Bispecific antibodies are a rapidly growing class of therapeutic molecules, originally developed for the treatment of cancer but recently explored for the treatment of autoimmune and infectious diseases. Bordetella pertussis is a reemerging pathogen, and several of the key symptoms of infection are...
Tallennettuna:
| Julkaisussa: | Clin Vaccine Immunol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5098018/ https://ncbi.nlm.nih.gov/pubmed/27581436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00371-16 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|